CHARTER LIFE SCIENCES
Charter Life Sciences is a clinical-stage venture capital firm focused on investments in early-stage opportunities.
CHARTER LIFE SCIENCES
Social Links:
Industry:
Biotechnology Financial Services Life Science Venture Capital
Status:
Closed
Technology used in webpage:
Microsoft Exchange Online Network Solutions DNS
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Clarus Ventures
Clarus Ventures is a Massachusetts-based venture capital firm focused on investments in the healthcare sector.
Mobius Venture Capital
Mobius Venture Capital is an early-stage venture capital fund that invests in various sectors, including healthcare and infrastructure.
Novus Biotechnology Fund
Novus Biotechnology Fund operates as an early-stage venture capital firm that makes investments in territories such as the US.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2014-09-11 | Prevacept Infection Control | Charter Life Sciences investment in Venture Round - Prevacept Infection Control | 11.22 M USD |
| 2013-12-03 | Xlumena | Charter Life Sciences investment in Series C - Xlumena | 25 M USD |
| 2013-10-08 | Amaranth Medical | Charter Life Sciences investment in Series B - Amaranth Medical | 20 M USD |
| 2013-06-17 | Minimally invasive devices | Charter Life Sciences investment in Series B - Minimally invasive devices | 2.5 M USD |
| 2013-03-25 | Minimally invasive devices | Charter Life Sciences investment in Series B - Minimally invasive devices | 9 M USD |
| 2011-04-29 | Xlumena | Charter Life Sciences investment in Series B - Xlumena | 7 M USD |
| 2010-08-23 | Prevacept Infection Control | Charter Life Sciences investment in Series B - Prevacept Infection Control | 3.1 M USD |
| 2010-04-30 | Corepair | Charter Life Sciences investment in Series C - Corepair | 4.49 M USD |
| 2009-11-05 | CymaBay Therapeutics | Charter Life Sciences investment in Series E - CymaBay Therapeutics | 8.6 M USD |
| 2009-10-06 | Inviragen | Charter Life Sciences investment in Series A - Inviragen | 15 M USD |